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Current Opinion
The past 30 years have been deemed the golden age of head and
neck oncology. With improvements in diagnostic surveillance
and therapeutic intervention, advances in patient care have
resulted in overall improved survival and quality of life for
those affected. Management of tumours of the cranial base, a
unique subset of head and neck tumours, has also undergone
a renaissance of sorts, with more aggressive resections and
expanding multimodality therapy. In this paper, we review
existing information concerning the outcomes of manage-
ment of these tumours and present a rationale for therapy of
skull-base tumours.
Surgical therapy of cranial-base tumours is a relatively new
concept. Just as neurosurgeons once deemed intracranial tu-
mours with cranial-base involvement unresectable, head and
neck surgeons originally had little success with these types of
lesions, feeling classical approaches (such as lateral rhinotomy)
precluded safe and complete resection of masses breeching the
skull base. A unimodal approach was recognized as insuffi-
cient for surgical management of these tumours. As surgical
oncology progressed with the concept of en bloc resection, the
desire of surgeons to resect complete anatomical units re-
sulted in the development of novel approaches to cranial-base
tumours. Dandy first published his experience with a com-
bined intracranial and extracranial approach in 1941 in his
work with orbital tumours.1 This combined approach gained
popularity and was adopted by head and neck surgeons, via
Ketcham et al in 1963,2 for the resection of paranasal sinus
malignancies via anterior craniofacial resections.
The advent of the combined approach to cranial-base
surgery stemmed from a collaboration between head and neck
surgeons and neurosurgeons. Since then, the range of diag-
nostic and therapeutic options available has expanded and the
interdisciplinary relationship has grown to involve an increas-
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ing number of physician groups as well as ancillary personnel;
each group plays a key role in the care of these patients. The
team approach is essential to proper care and should involve
head and neck surgeons, neurosurgeons, intraoperative pa-
thologists, plastic and reconstructive surgeons, medical and
radiation oncologists, neuroradiologists, speech patholo-
gists, physical and occupational therapists, and prosthodon-
tists. With these global advances, surgeons can perform more
complex procedures for these patients, but the question as to
whether these advances improve patient outcome arises.
The data for cranial-base surgery are limited and have
generally been presented as case studies or retrospective
analyses. Prospective clinical trials to investigate important
issues, especially outcome measures, have not been performed
and would be extremely difficult due to the limited experience
in most centres, tumour variables (pathological type, grade
and stage), and patient variables (general condition, prior
disease, surgery or radiation), as well as the difficulty of stan-
dardizing treatment algorithms for these various diseases.
There is also a lack of uniformity among investigators in the
reporting of the specifics of these patients and their tumours.
In general, an analysis of our current rationale for therapy is
based on published retrospective studies that are somewhat
limited and difficult to compare and extrapolate.
The historical aspect of cranial-base surgery was reviewed
by O’Malley and Janecka, who described a progression through
several periods, each of which has seen surgical advances and
increased survival.3 The first era, from the 1960s to the 1970s,
can be characterized by a high complication rate and poor
survival despite large selection bias because many patients
were deemed inoperable due to extensive local involvement.
The authors of studies reviewed for this time period did not
operate on certain tumours such as those extending into the
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pterygopalatine fossa or intracranially. The second era, from
the 1970s to the 1980s, showed similar complication and sur-
vival rates, despite the more extensive procedures performed.
More aggressive techniques allowed the removal of infratem-
poral and pterygopalatine fossa tumours as well as neoplasms
extending intracranially and even intraparenchymally. Dur-
ing the third period of skull-base surgery (1980s and beyond),
these extensive procedures continued to be performed with
improved local control, a significant decrease in complication
rates, and an improvement in survival (Table). However, this
analysis did not address functional status as an outcome
measure.
Janecka et al published results from 183 patients who
underwent surgery for cranial-base tumours, 67% of which
were malignant (most commonly squamous cell carcinoma
and adenoid cystic carcinoma).4 From a surgical point of view,
negative margins were achieved in 44% of patients. Oncolo-
gical results showed a 30-month survival of 67%, with no
evidence of disease in 63%. The overall complication rate
was 33% (21% surgical, 12% medical). Overall functional status,
as measured by the Karnofsky scale, was improved: 39% of
patients were improved, 44% were unchanged, and 15% scored
lower postoperatively.
Another outcome analysis, published in 1994 by Irish et al,
concerned 77 cases of skull-base tumours.5 In an effort to
organize their results and to improve standardization of
reporting for cranial-base tumours, a staging system based on
anatomical location was introduced. The delineation of these
regions (I, II and III) are based on the portion of the skull base
involved and also correlate somewhat with the approach needed
for resection. Region I involves the anterior cranial fossa and
the clivus; most of these tumours originate in the paranasal
sinuses or intracranially, and are approached via craniofacial
resection. Region II tumours involve the middle cranial fossa,
generally via direct extension from pterygopalatine or in-
fratemporal fossa tumours through the foramina. Region III
tumours originate in or near the temporal bone and extend
into the middle or posterior cranial fossa. In general, region II
and III tumours are surgically approached using a more lateral
procedure, such as an infratemporal approach, facial trans-
location or a variant of temporal-bone resection.
When surgical outcomes were analysed for each anatomi-
cal subunit, patients with region II tumours had very poor
survival, 45% at 2 years and 0% at 4 years (n = 7), despite a lo-
wer malignancy rate (71%) than the other regions (I = 76%,
III = 88%). The overall 2- and 4-year survival rates were 80% and
71% (n = 77), which shows that patients with pterygopala-
tine and infratemporal fossa tumours involving the skull base
have a very poor prognosis despite aggressive surgical resec-
tion. The overall complication rate in this study was 44% and
increased dramatically to 64% in cases with tumours involving
more than one region and requiring more extensive resection.
Despite its limited size, this study infers a reanalysis of the
management of certain cranial-base tumours, especially exten-
sive, region II tumours.
Shah et al reported their experience with craniofacial re-
section for anterior cranial-base tumours in 1992 (n = 71).6
Remarkable results include no difference in survival between
previously treated and untreated patients. Also, local control
was achieved in 71% of patients with negative margins and 67%
of patients with positive margins. O’Malley and Janecka have
also reported no statistically significant difference in survival
between patients with positive and negative margins.3 This
underscores the importance of the surgeon’s interpretation
and use of pathology in these cases. In general, it is extremely
difficult to fully and properly inspect the entire three-dimen-
sional margins of such a large en bloc resection. Intraoperative
consultation with a pathologist is important in order to prop-
erly orient the specimen and to inform the pathologist of
pertinent patient and surgical details. Survival rates for tu-
mours involving the dura were not statistically different from
those involving the brain parenchyma; however, these patients
fared much worse than those without penetration of the dura
(p = 0.02) in terms of survival.
Despite the surgeon’s expanding armamentarium, one
must focus on endpoint analysis. First, the detection of both
primary and recurrent neoplasms has become much more
sensitive and offers more information concerning surround-
ing structures. Although data may be somewhat obscured at
some tissue interfaces, bony invasion is more reliably detected
with advances in computed tomography. Magnetic resonance
imaging allows determination of the degree and extent of
dural and intraparenchymal involvement.7 Image-guided sur-
gery uses both of these resources and can improve orientation
and familiarization with the surgical landscape. Also, positron
emission tomography shows promise for the early detection of
Table. Rates of local control and survival for the three eras of
cranial-base surgery
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recurrent disease. Arteriography, carotid artery balloon occlu-
sion and xenon blood-flow studies are now available to help
estimate the results of carotid embarrassment or the need for
carotid bypass. Advanced techniques in endoscopic sinus sur-
gery allow less invasive approaches to craniofacial resections
and can preclude the need for facial incisions.8 Also, advances
in technique and instrumentation for microsurgery (especially
involving the cavernous sinus),9 brachytherapy, nerve graft-
ing10 and radiotherapy (including stereotactic radiation)11
offer more diverse treatment options, but the impact of each
is difficult to isolate at this time.
Perhaps the most important issue that has affected cra-
nial-base surgery deals with the advancements in reconstruc-
tion of these potentially large en bloc resections. The moderni-
zation of techniques for local fascial flap (especially the tem-
poroparietal fascial flap) and myocutaneous pedicled flap,
and the development of the microvascular free flap allow more
appropriate and viable reconstructions and help separate in-
tracranial and extracranial contents. Several authors have
postulated that these advances in separation (especially when
dealing with craniofacial resections and the nasal cavity) are
responsible for the decreased complication rate in the third era
of cranial-base surgery.12
In the past 15 years, we have managed more than 3,100
head and neck malignancies. Those invading the infratem-
poral skull base, sphenoid sinus, clivus and brain have been
universally fatal by 5 years. Multimodal therapy (surgery,
radiation and chemotherapy) has not improved the progno-
sis for these tumours. From our experience and the published
literature, management of malignancies of the head and neck
that invade the infratemporal skull base has involved various
radiotherapeutic modalities over the past decade due to the
extremely poor prognosis for these lesions. For malignant
skull-base tumours, contraindications for resection at our
institution include involvement of brain parenchyma and
invasion of the walls of the sphenoid sinus (except the ante-
rior wall), the clivus, the intrapetrous carotid, the optic chi-
asm or the infratemporal skull base. Piecemeal removal of
malignant lesions with microscopic close margins can only be
condemned. Although the pathologist’s role is pivotal in this
situation, only the surgeon knows the adequacy of his or her
resection.
When dealing with benign skull-base tumours, the extent
of resection must be balanced against iatrogenic neurological
compromise, with care to leave the patient with an acceptable
functional status. We have performed 107 craniofacial resec-
tions over this period with similar results to those described in
the literature, except for patients with sinonasal undifferenti-
ated carcinoma, where the success has been dismal. Extensive
discussion with the patient is crucial, and the following are
used as contraindications for resection of benign tumours at
our institution: extensive involvement of both cavernous si-
nuses where significant neurovascular injury would occur,
involvement of the brainstem with pontine blood supply to
the tumour that cannot be separated from the pons, and in-
volvement of the optic chiasm where the tumour cannot be
separated without sacrificing both optic nerves. The following
are not advised: resection of sufficient craniofacial structures
to make reconstruction unacceptable, resection involving bi-
lateral long-tract cranial nerves, and resection of sufficient
brain parenchyma (especially the dominant temporal lobe)
that may make the patient severely debilitated.
In conclusion, our rationale for therapy of cranial-base
tumours is individually tailored by a team of physicians and
somewhat molded by the patient’s wishes. It is of utmost
importance that patients and their families have an under-
standing of what morbidity is anticipated and the extent of the
neurological compromise. Although surgeons have an in-
creasing ability to perform and reconstruct extensive en bloc
resections of cranial-base tumours, it is questionable whether
these procedures improve patient outcome in all instances.
The surgeon and the patient, as leaders of the therapeutic
team, are best prepared to develop their rationale for therapy
armed with the knowledge of existing outcome analyses tai-
lored to each patient’s specific case.
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